Christine M. Evangelista

Statistics

Publications

Citations

229

H-Index

Active since

2001

Affiliations

Duke University Hospital(Current)

Amgen (United States)

Duke Medical Center

University of Maryland, Baltimore

Christine M. Evangelista is an author at Duke University Hospital specializing in inflammatory bowel disease activity assessment, cell signaling, and biochemistry.

Publications per year

2001–2018

Publications

Efficacy and Safety of Abrilumab in a Randomized, Placebo-Controlled Trial for Moderate-to-Severe Ulcerative Colitis

William J. Sandborn, Marcoli Cyrille, Mark Berner Hansen et al. · Gastroenterology · 2018 · 87 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +17

N‐terminal PDZ domain is required for NHERF dimerization

Shirish Shenolikar, Charles Minkoff, Deborah Steplock et al. · FEBS Letters · 2001 · 71 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +13

Essential Role for NHERF in cAMP-mediated Inhibition of the Na+-HCO3-Co-transporter in BSC-1 Cells

Edward J. Weinman, Christine M. Evangelista, Deborah Steplock et al. · Journal of Biological Chemistry · 2001 · 36 citations · Full text

Life Sciences, Biochemistry, Pharmacology +14

Clinical pharmacology of <scp>AMG</scp> 181, a gut‐specific human anti‐α<sub>4</sub>β<sub>7</sub> monoclonal antibody, for treating inflammatory bowel diseases

Wei‐Jian Pan, Kathleen Köck, William A. Rees et al. · British Journal of Clinical Pharmacology · 2014 · 35 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

1–4 of 4